Weight Loss (WL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Correlates With Improvements in Liver Function in Overweight/Obese Adults With Elevated Alanine Aminotransferase (ALT)

被引：0

作者：

Klein, Samuel

Najarian, Thomas

Troupin, Barbara

Day, Wesley W.

机构：

来源：

OBESITY | 2011年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S177 / S177

页数：1

相关论文

共 37 条

[1] Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Hunger and Satiety, Leading to Weight Loss in Overweight/Obese Adults
Day, Wesley W.
Najarian, Thomas
Troupin, Barbara
Tam, Peter
Peterson, Craig
OBESITY, 2010, 18 : S154 - S154
[2] Improvements in Quality of Life (QoL) With Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) in Overweight/Obese Subjects
Kolotkin, Ronette L.
Peterson, Craig
Gadde, Kishore M.
OBESITY, 2010, 18 : S155 - S155
[3] Weight Loss With Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Improves Plasma Alanine Transaminase (ALT) Concentrations
Klein, Samuel
Najarian, Thomas
Day, Wesley W.
OBESITY, 2010, 18 : S155 - S155
[4] Long-term glycaemic effects of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR) in overweight/obese subjects with diabetes
Van Gaal, L. F.
Cheskin, L. J.
Najarian, T.
Day, W. W.
Peterson, C. A.
DIABETOLOGIA, 2011, 54 : S371 - S371
[5] Changes in Insulin Sensitivity in Overweight/Obese Patients Treated with Low-Dose, Controlled-Release Phentermine/Topiramate(PHEN/TPM)
Garvey, W. Timothy
Gadde, Kishore
Tam, Peter
Peterson, Craig
DIABETES, 2010, 59 : A481 - A481
[6] Long-Term Weight Loss and Improvement in Glycemic Parameters with Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM CR)
Kushner, Robert F.
Garvey, W. Timothy
Troupin, Barbara
Day, Wesley W.
DIABETES, 2011, 60 : A515 - A515
[7] Severely Obese Adults Administered Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Maintained Their Weight Loss in the Second Year
Gadde, Kishore M.
Allison, David B.
Tam, Peter
Troupin, Barbara
OBESITY, 2011, 19 : S176 - S176
[8] Amount of cardiometabolic risk reduction is directly associated with magnitude of weight loss with low-dose, controlled-release phentermine/topiramate (PHEN/TPM CR)
Klein, S.
Tam, P.
Peterson, C.
DIABETES OBESITY & METABOLISM, 2010, 12 : 52 - 52
[9] EFFECT OF WEIGHT LOSS WITH PHENTERMINE/TOPIRAMATE CR ON ALANINE AMINOTRANSFERASE CONCENTRATIONS IN OVERWEIGHT/OBESE ADULTS
Klein, Samuel
Najarian, Thomas
Bowden, Charles H.
Day, Wesley W.
HEPATOLOGY, 2010, 52 (04) : 651A - 651A
[10] Weight Loss (WL) and Change in Antidiabetic Medications Over 2 Years With Controlled-Release Phentermine/ Topiramate (PHEN/TPM CR)
Kushner, Robert F.
Troupin, Barbara
DIABETES, 2012, 61 : A507 - A507

← 1 2 3 4 →